LAG3 and hepatocellular carcinoma: Anti-PD-1 mAb and STING agonists have shown notable synergy in upregulating LAG-3 expression on TILs in HCC, which can be successfully tracked by [68Ga]Ga-NOTA-C25 PET imaging.